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https://doi.org/10.1016/j.stemcr.2018.01.036SUMMARYThe epithelial compartment of the mammary gland contains basal and luminal cell lineages, as well as stem and progenitor cells that
reside upstream in the differentiation hierarchy. Stem andprogenitor cell differentiation is regulated tomaintain adult tissue andmediate
expansion during pregnancy and lactation. The genetic factors that regulate the transition of cells between differentiation states remain
incompletely understood. Here, we present a genome-scale method to discover genes driving cell-state specification. Applying this
method,we identify a transcription factor, BCL11B,which drives stem cell self-renewal in vitro, by inhibiting differentiation into the basal
lineage. To validate BCL11B’s functional role, we use two-dimensional colony-forming and three-dimensional tissue differentiation as-
says to assess the lineage differentiation potential and functional abilities of primary human mammary cells. These findings show that
BCL11B regulatesmammary cell differentiation and demonstrate the utility of our proposed genome-scale strategy for identifying lineage
regulators in mammalian tissues.INTRODUCTION
Adult tissues are maintained through the regulated self-
renewal and differentiation of stem cells that give rise to
differentiated cell types. Themammary epithelium typifies
this process by undergoing cyclic expansion and contrac-
tion during the estrous cycle and further differentiating
during pregnancy and lactation (Fata et al., 2001; Macias
and Hinck, 2012; Schedin et al., 2000). This extensive tis-
sue turnover demands a continuous source of newly
minted differentiated cells of both the luminal and basal
epithelial lineages. While the existence of both bipotent
and lineage-restricted mammary stem cells (MaSCs) has
been established (Davis et al., 2016; Inman et al., 2015;
Pal et al., 2017; Rios et al., 2014; Scheele et al., 2017;
Shackleton et al., 2006; Stingl et al., 2005, 2006; Van Key-
meulen et al., 2017; Van Keymeulen et al., 2011; Visvader
and Stingl, 2014; Wang et al., 2015), relatively little is
known about the genes that regulate the self-renewal or dif-
ferentiation of these stem and progenitor cell types.
The identification of self-renewal and lineage commit-
ment regulators in the human mammary gland has been
complicated by two main factors. First, while cell surface
markers often enrich for stem and more differentiated
cell states, they rarely allow investigators to isolate pure
subpopulations of mammary epithelial cells (MECs). The
absence of definitive markers, particularly those distin-Stem Cell Rep
This is an open access article under the Cguishing MaSCs from differentiated cells of the basal line-
age, precludes the use of transcriptomic or other profiling
strategies to identify candidate regulators that commit
bipotent cells to the basal lineage. Second, while powerful
transplantation and lineage tracing assays are available for
study of the murine mammary gland, a lack of appropriate
experimental models precludes similar analyses in human
cells (Visvader and Stingl, 2014). While the mouse has
been indispensably valuable as an experimental model,
murine mammary glands display morphological, develop-
mental, and genomic differences when compared with the
human gland (Carroll et al., 2017; Fridriksdottir et al., 2011;
Visvader, 2009), suggesting that rodents may not fully
replicate aspects of the biology of human mammary
tissue. This latter limitation was partially addressed by the
recent development of three-dimensional (3D) culture
models that support the outgrowth of morphologically
complex mammary tissue from primary human MECs
(Miller et al., 2017; Sokol et al., 2016).
This study was motivated by the need for systematic
methods to identify functional regulators of stem and pro-
genitor cell states. We approached this problem by
observing that genes whose expression is sufficient to
specify a particular cell lineage would need to be stably
repressed in other cell lineages to prevent aberrant differen-
tiation (Mall et al., 2017; Schafer et al., 1990; Schoenherr
and Anderson, 1995; Terranova et al., 2006). In principle,orts j Vol. 10 j 1131–1145 j March 13, 2018 j ª 2018 The Authors. 1131
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this observation provides a means of distinguishing be-
tween downstream markers and key functional regulators
of a cell state. Thus, in a mixed population of cells contain-
ing two cell lineages, genes sufficient to alter a cell’s state
would be stably repressed in one lineage and expressed in
the other. Even though such genes would either be ex-
pressed or repressed in any given cell, profiling of a popula-
tion of cells would show that such genes display epigenetic
marks associated with both gene repression (histone
H3K27me3) and active expression (histone H3K4me3)
(Barski et al., 2007; Koch et al., 2007).
We use an additional feature to distinguish such ‘‘pseudo-
bivalent’’ genes (J-bivalent), expressed in some cell types
and repressed in others, from genes that are uniformly
bivalent and thus poised for expression (though not actu-
ally expressed) in all of the cells within a population. At
an epigenetic level, J-bivalent genes can be distinguished
from truly bivalent genes by markers of transcriptional
elongation (histone H3K79me2) and the presence of tran-
scribed mRNAs. We hypothesized that J-bivalent genes
encompass functionally significant regulators of stem cell
self-renewal and lineage commitment. Here, we identify a
cohort of such J-bivalent genes in a mammary stem/pro-
genitor cell line. We validate the role of one of these genes,
BCL11B, in driving the self-renewal of primary human
multipotentMaSCs in two-dimensional (2D) and 3D assays
of progenitor activity, differentiation potential, and tissue
development. Furthermore, we show that BCL11B func-
tions to maintain in vitro multipotency by specifically in-
hibiting basal lineage commitment.RESULTS
Identification of Pseudo-bivalent TFs as Candidate
Cell Lineage Specifiers
To identify candidate genes regulating cell state, we used
the MCF10A cell line as a model system (Soule et al.,
1990). When seeded into 3D collagen gels, single
MCF10A cells can form morphologically complex ductal-
lobular tissue rudiments (organoids) (Figures 1A and 1B),
indicating that this line contains bipotent stem cells
capable of differentiating and self-organizing into the
tree-like architecture characteristic of mammary tissue. In
addition to forming ductal-lobular organoids, single
MCF10A cells also form either duct-only or lobule-only
organoids, indicating the presence of lineage-committed
progenitors (Figure 1B). Because this cell line contains the
lineage-committed basal and luminal progenitor cell states
required for tissue morphogenesis (Krause et al., 2008;
Sarrio et al., 2012; Sokol et al., 2015), we set out to identify
differentially expressed transcription factors (TFs) thatmay
specify these states.1132 Stem Cell Reports j Vol. 10 j 1131–1145 j March 13, 2018While many factors are differentially expressed between
cell states, we were interested specifically in factors capable
of reprogramming cellular lineage. We reasoned that the
promoters of such factors would be actively repressed in
other lineages, since, if this were not the case, stochastic
fluctuations in their expression could lead to inappropriate
lineage switching. Thus, a factor capable of driving cells
into lineage A would be expressed in cells of that lineage
while stably repressed in other cell lineages. We identified
such factors using chromatin immunoprecipitation
sequencing (ChIP-seq) against histone modifications
marking transcriptional activation (H3K4me3), transcrip-
tional repression (H3K27me3), and active transcriptional
elongation (H3K79me2) (Figures 1C and 1D).
Based on the above reasoning, we were interested specif-
ically in finding J-bivalent TFs that appeared bivalent on
the population level but were in fact either expressed or
repressed in individual cells (Figure 1C). These factors
would be stably activated (H3K4me3+ promoter) in a subset
of cells and stably repressed (H3K27me3+ promoter) in
another subpopulation. We identified a total 1,895
H3K4me3+ TFs and 1,135 H3K27me3+ TFs. We identified
55 TFs whose promoters were marked with both
H3K4me3 and H3K27me3 peaks on the population level
(see Experimental Procedures for details on peak calling).
Of these bivalent TFs, 23 also contained H3K79me2 peaks
within their gene body, indicating active elongation, sug-
gesting that the majority of these genes were expressed in
a subset of cells. However, since H3K79 methylation status
is regulated in part by cell cycle status (Schulze et al., 2009),
to definitively identify genes being actively transcribed we
performed RT-PCR, which revealed that 48 of the bivalent
TFs expressed detectable mRNAs on the population
level (Table S1 and Figure 1E). We classified these 48 TFs
as J-bivalent candidate regulators of differentiation.
Candidate Regulatory TFs Mark Cell States in the
Human Mammary Gland
To determine whether any of these candidate regulatory
TFs play a role in human MEC identity, we asked whether
their expression distinguishes mature cell types within
the human gland in vivo. We collected single cells from
elective patient reduction mammoplasty tissue and per-
formed single-cell qPCR to quantify expression of the
48 candidate TFs, as well as established cell-state markers
(Figure 2A). Using unsupervised hierarchical clustering
(Figure 2B) and principal component dimensionality
reduction (Figure 2C), the cells separated into three distinct
clusters. Cells in two of the clusters expressed markers of
the basal lineage (CD10, SNAI1, SNAI2, ITGA6) (Ballard
et al., 2015; Moritani et al., 2002; Sarrio et al., 2012; Stingl
et al., 2006; Villadsen et al., 2007), whereas a third cluster
contained cells enriched for higher expression of luminal
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Figure 1. Discovery of Candidate Lineage Specifiers in the MCF10A Mammary Stem Cell Line
(A) Schematic showing the seeding of MCF10A cells into 3D collagen cultures, and the formation of organoids.
(B) Representative confocal microscopy images showing examples of MCF10A organoids after 8 days of 3D culture. Examples of acinar
organoids are indicated with arrowheads, ductal organoids are indicated with arrows, and ductal-lobular organoids are indicated with
asterisks. Scale bars, 50 mm.
(C) Schematic depiction of epigenetic marks at active, repressed, bivalent, and J-bivalent genes.
(D) Representative results of ChIP-seq run for histone H3K4me3, histone H3K27me3, and histone H3K79me2, showing active, repressed,
bivalent, and pseudo-bivalent genes in a mixed population of MCF10A cells.
(E) Summary of bivalent and J-bivalent TF loci calls from ChIP-seq and RT-PCR results.lineage markers (EPCAM, GATA3, SOX9, KRT18, ETV6)
(Abd El-Rehim et al., 2004; Asselin-Labat et al., 2007;
Guo et al., 2012; Kouros-Mehr et al., 2006; Shehata et al.,
2012; Su et al., 1996; Taylor-Papadimitriou et al., 1989; Tog-
non et al., 2002) (Figures 2B and 2D).
Each of these three clusters showed statistically signifi-
cant enrichment of expression of at least one of our candi-
date regulatory TFs (Wilcoxon rank-sum test, p < 0.01;
Figure 2D). The luminal cluster was enriched for expression
of ATF3, BARX2, and ZNF175. Basal cluster 1, which ex-
presses high levels of the epithelial to mesenchymal transi-
tion (EMT) TF, SNAI1, was also enriched for the expression
of FLI1. Basal cluster 2, which expresses high levels of the
basal markers SNAI2 and CD10, was also enriched for the
expression of another EMT TF, ZEB2. Notably, a recent
study by Bach et al. (2017) identified a subpopulation ofbasal cells in the murine mammary gland that was also en-
riched for Zeb2 expression, raising the possibility that basal
cluster 2 represents a human homolog of this murine cell
state. In summary, our findings raise the possibility that
two distinct human basal epithelial cell types exist, which
may be regulated by FLI1 and ZEB2, respectively.
Candidate Regulatory TFs Are Enriched in Cultured
Primary MaSCs
In order to determine whether any of these 48 candidate
cell-state specifiers controlled the MaSC state, we first
needed to enrich stem and progenitor cells from our pa-
tient sample. To do so, we used a recently describedmethod
(Miller et al., 2017; Sokol et al., 2016) of in vitro culture of
freshly isolated primary cells in 3D hydrogels to expand
stem and progenitor cells (Figure 3A).When grown in theseStem Cell Reports j Vol. 10 j 1131–1145 j March 13, 2018 1133
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Figure 3. Expansion of Primary Human Mammary Stem/Progenitor Cells in 3D Hydrogel Culture
(A) Schematic showing the seeding of primary MECs in 2D colony-forming assays, before and after culture in 3D hydrogels, to assay stem/
progenitor activity. 10d, 10 days; 14d, 14 days.
(B) Representative brightfield microscopy images of tissue rudiments formed from single primary MECs. Scale bar, 100 mm.
(C) Quantification of colony-forming efficiency in uncultured primary cells and 3D hydrogel-cultured cells. Data plotted are normalized to
primary cells, and demonstrate a roughly 18-fold increase in stem/progenitor activity in cells cultured in 3D hydrogels (n = 3 independent
experiments).
(D) Gene expression, as determined by single-cell qPCR, in primary cells and 3D hydrogel-cultured cells. Expression values are gene
normalized and set to a range from 0 to 1. Box and whiskers plot depicts the median, interquartile range, and minimum and maximum
values.
Error bars represent mean ± SD. *p < 0.05 by Student’s t test.hydrogels, single cells form simple 3D structures over the
course of 14 days (Figure 3B). The cells within these imma-
ture structures are strongly enriched for stem/progenitor
cell states, as demonstrated by a roughly 18-fold increase
in colony formation when plated in 2D culture (Figure 3C).
These cultured cells express higher levels of KRT14, indi-
cating an expansion of the basal population, which con-
tains all of the bipotent stem cell activity in the mammaryFigure 2. Candidate Lineage Specifiers Distinguish Luminal and B
(A) Schematic depicting the isolation of patient mammary epithelial
(B) Single-cell qPCR of established cell-state markers and candidate
clusters of cells.
(C) Principal component analysis of single-cell gene expression data
(D) Enrichment of expression of each gene is plotted for each of the th
enriched in a cluster, relative to cells outside of that cluster (p < 0.0epithelium. They also express higher levels of SNAI2
and SOX9, whose co-expression is required for the stem
cell state in the mouse mammary epithelium (Guo et al.,
2012) (Figure 3D).
To determine whether any of our 48 candidate cell-state
regulatory TFs were enriched in these cultured stem/pro-
genitor cells, we performed single-cell qPCR. This analysis
revealed two clusters of cultured cells: a basal clusterasal Cell Types in Primary Human Mammary Epithelial Cells
cells and single-cell qPCR.
lineage-specifying TFs results in one luminal cluster and two basal
shows three distinct clusters of cells.
ree clusters. Colored and labeled points indicate genes significantly
1 by Wilcoxon rank-sum test).
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Figure 4. Expression of BCL11B Is Enriched in Human Mammary Stem/Progenitor Cells
(A) Results of single-cell qPCR of established cell-state markers and candidate lineage-specifying TFs in primary MECs cultured in 3D
hydrogels for 14 days. Cells separate into a cluster composed of basal stem/progenitor cells (indicated by co-expression of SNAI2 and SOX9)
and luminal progenitor cells (expressing SOX9, but not SNAI2).
(B) Normalized gene expression of three cell-state markers (EPCAM, GATA3, and ITGA6) is not significantly changed, but four candidate
lineage-specifying TFs (BCL11B, TCF7, HOXC13, and LMX1B) are significantly enriched (p < 0.01 by Mann-Whitney test) in cultured MECs (3D
hydrogel) relative to uncultured (primary) cells (n = 121 primary cells and 94 3D hydrogel-cultured cells).
(C) Normalized gene expression of BCL11B, TCF7, HOXC13, and LMX1B in cultured cells from the two clusters is plotted (n = 64 basal cells and
30 luminal cells).marked by enriched ITGA6 and KRT14 expression and a
luminal cluster marked by enriched EPCAM expression
(Figure 4A). Comparing expression of our candidate TFs
in stem/progenitor cells with mature primary cells, we
found four TFs with significantly increased expression in
stem/progenitor cells: BCL11B, HOXC13, LMX1B, and
TCF7 (Figure 4B). Of these four genes, BCL11B was most
restricted to the basal population, which contains the bipo-
tent MaSCs (Figure 4C). We therefore set out to test the role
of BCL11B in the differentiation and self-renewal of hu-
man MaSCs.1136 Stem Cell Reports j Vol. 10 j 1131–1145 j March 13, 2018BCL11B Is Required for the Self-Renewal of 3D
Cultured MCF10A Cells
First, we examined the expression of BCL11B protein in
MCF10A cells. As predicted by its epigenetic J-bivalence,
we found its expression to be heterogeneous, with some
cells not detectably expressing protein and other express-
ing high levels of protein (Figures 5A and 5B). Next we
set out to test the functional role of BCL11B in MCF10A
cell self-renewal and differentiation. We used two indepen-
dent short hairpin RNAs (shRNAs) to inhibit expression of
BCL11B (Figure 5C), neither of which affected the growth
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Figure 5. BCL11B Is Required for MCF10A Self-Renewal and Duct Formation
(A) Immunofluorescent staining of BCL11B protein expression. Representative of three independent replicates. Scale bar, 50 mm.
(B) Histogram showing quantification of BCL11B from (A) (n = 228 cells).
(C) Demonstration of knockdown of BCL11B expression, by qPCR, in MCF10A cells (left) or primary patient MECs (right) transduced with two
shRNAs. Plotted is expression relative to uninfected control, normalized to GAPDH (n = 4 independent experiments).
(D) Growth curves showing no difference in growth rate of MCF10A cells transduced with shRNAs targeting BCL11B or Luciferase (shCntrl)
(n = 3 independent experiments).
(E) Representative images of MCF10A cells transduced with either shRNAs targeting BCL11B or Luciferase (shCntrl), grown in 3D culture for
7 days and stained with DAPI (blue) and phalloidin (green). Scale bars, 200 mm (n = 4 independent experiments).
(F) Quantification of the size of organoids from (E) (n = 4 independent experiments).
(G) Quantification of the ratio of ductal organoids to acinar organoids from (E) (n = 4 independent experiments).
(H) Quantification of the fraction of MCF10A cells from the three lines that are capable of giving rise to secondary organoids after being
removed from primary 3D culture and reseeded (n = 3 independent experiments).
Error bars represent mean ± SD. *p < 0.05 by Student’s t test.rate of the cells in 2D culture (Figure 5D).When seeded into
3D culture, MCF10A cells with inhibited expression of
BCL11B prematurely differentiate, as indicated by a reduc-
tion in organoid size (Figures 5E and 5F), failure to formacini (Figures 5E and 5G), and loss of ability to repopulate
new organoids when reseeded into secondary 3D cultures
(Figure 5H). These phenotypes all pointed toward a loss
of MCF10A self-renewal upon inhibition of BCL11BStem Cell Reports j Vol. 10 j 1131–1145 j March 13, 2018 1137
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when cells are grown in differentiating conditions (3D
culture).
BCL11BDrives PrimaryHumanMaSC Self-Renewal by
Inhibiting Basal Differentiation
To determine the role of BCL11B in the differentiation of
primary human stem and progenitor cells in vitro, we per-
formed a canonical 2D plate differentiation assay in wild-
type patient cells and in cells transduced with shRNAs
targeting BCL11B. Inhibition of BCL11B in two indepen-
dent patient samples did not affect the formation of
luminal colonies or mixed luminal-basal colonies. How-
ever, the fraction of bipotent stem cell colonies, identified
in this assay by the presence of co-expression of luminal
and basal markers (Clayton et al., 2004; Proia et al.,
2011; Smalley et al., 1998; Sokol et al., 2015; Stingl
et al., 2001), dropped significantly, indicative of a loss of
bipotent stem cell self-renewal in these in vitro conditions
(Lim et al., 2009; Petersen and Polyak, 2010; Santagata
et al., 2014). This was accompanied by a reciprocal in-
crease in mature basal colonies, indicating that, rather
than self-renewing, stem cells were differentiating
into basal progenitors in the absence of BCL11B (Figures
6A and 6B).
In addition to the shift in colony ratios, stem colonies
and colonies of mixed lineage were significantly smaller
when BCL11B expression was inhibited, indicating
decreased self-renewal of the bipotent cells that give rise
to these colonies (Figure 6C). Mixed lineage colonies also
showed an increase in the fraction of basal cells within
the colony, indicating a bias toward basal differentiation
upon loss of BCL11B (Figure 6D).
A recent study by Cai et al. (2017) found that, in murine
MECs, Bcl11b drives a quiescent MaSC state, inconsistent
with our demonstration of a functional role of BCL11B in
driving self-renewal in proliferating MaSCs. Recent ad-
vances in the study of mammary epithelial biologyFigure 6. BCL11B Drives Self-Renewal of Primary Human MaSCs b
(A) Demonstration of automated colony-scoring pipeline and represen
primary human MECs grown for 10 days in 2D culture. Scale bar, 50 m
(B) Two independent patient samples show an increase in basal colo
inhibition of BCL11B, relative to control shRNA.
(C) Quantification of colony size shows decreased size of mixed and s
(D) Mixed colonies show an increase in the fraction of basal cells wh
pendent experiments per patient, with a total of 139 patient 1 shCnt
colonies, and 87 patient 2 shBCL11B colonies.
(E) Four representative immunofluorescence images of primary human
(blue). The dotted regions are enlarged at right, and individual ch
BCL11B+/Ki-67+ cells, while the two fields on the right show example
patient samples). Scale bars, 20 mm.
(F) Quantification of Ki-67 staining from (E). Plotted is the percenta
(gray bar) that expressed Ki-67 (n = 3 independent patient samples)
Error bars represent mean ± SD. *p < 0.05 by Student’s t test.have raised concerns about the ability of canonical assays,
such as 2D colony formation and single-cell transplanta-
tion, to drive non-physiological dedifferentiation of
MECs (Chang et al., 2014; Lloyd-Lewis et al., 2017; Van
Keymeulen et al., 2011). In light of these findings, we
sought to interrogate the role of BCL11B in experimental
models that do not involve the isolation of single cells or
culture on 2D dishes. First, we sought to determine
whether BCL11B expression in human mammary cells
in vivowas predictive of proliferation or quiescence. Immu-
nofluorescence staining of freshly fixed human tissue
showed that this was not the case, as BCL11B-positive
MECs were more likely to express the proliferation marker
Ki-67 than BCL11B-negative MECs (Figures 6E and 6F).
Next, to examine the functional role of BCL11B in a
more native tissue development context, we turned to
our hydrogel culture system. When intact, patient-
derived tissue fragments consisting of hundreds of
epithelial cells are seeded into hydrogels and their growth
is driven by stem cell expansion, followed by differentia-
tion (Sokol et al., 2016). To determine BCL11B’s func-
tional role in this in vitro tissue development assay, we
infected patient tissues with lentiviral constructs driving
the expression of either a BCL11B-targeting shRNA and
GFP, or a control Luciferase-targeting shRNA and GFP (Fig-
ure 7A). This infection strategy leads to only a fraction of
the cells within a tissue being transduced with the virus,
allowing for the direct comparison of infected cells and
wild-type cells within a single tissue. In the shLuc-GFP
control, GFP-positive cells can be seen distributed
throughout the tissue, in both the outer basal layer and
the inner luminal layer. In contrast, in the shBCL11B-GFP
infected tissues, GFP-positive cells do not contribute to
new outgrowths from the tissue, and instead differentiate
into elongated basal cells, restricted to the core of the
structure (Figure 7B). This indicated that, in contrast
with the control shRNA, inhibition of BCL11B depletedy Inhibiting Basal Differentiation
tative basal, luminal, mixed, and stem colonies derived from single
m.
ny formation and subsequent decrease in stem colonies upon the
tem colonies upon inhibition of BCL11B, relative to control shRNA.
en BCL11B is inhibited, relative to control. For (B–D), n = 3 inde-
rl colonies, 150 patient 1 shBCL11B colonies, 115 patient 2 shCntrl
mammary tissue stained for BCL11B (red), Ki-67 (green), and DAPI
annels are depicted. The two fields on the left show examples of
s of BCL11B+/Ki-67 and BCL11B/Ki-67+ cells (n = 3 independent
ge of BCL11B-negative cells (black bar) and BCL11B-positive cells
.
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Figure 7. BCL11B Is Necessary for Growth of Primary Human Mammary Tissues in Hydrogel Culture
(A) Schematic showing the collection of primary human mammary epithelial tissue fragments, infection of tissues with lentiviral con-
structs, and seeding and growth of tissues in 3D hydrogel culture.
(B) Confocal microscopy images of tissues grown in culture for 14 days (representative of n = 6 independent experiments).
(C) Quantification of SOX9 and SNAI2 protein in hydrogel-cultured tissues infected with lentiviral shRNA constructs driving GFP as in
(A and B). Left: example of image segmentation of a representative tissue stained for SNAI2 and SOX9; segmentation analysis allows for
identification of GFP-positive and -negative cells, and quantification of SNAI2 and SOX9 expression in each cell. A shCntrl-GFP tissue is
depicted in this example. Right: quantification of SOX9 and SNAI2 is plotted for individual cells from shCntrl-GFP or shBCL11B-GFP infected
(legend continued on next page)
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stemness and drove basal differentiation in the infected
cells.
To determine the effect of BCL11B-knockdown on stem
cell self-renewal and lineage commitment, we cultured
patient cells in this assay for 2 weeks and then stained
for expression of SNAI2 and SOX9. In MECs, SNAI2 is a
marker of the basal lineage, SOX9 is a marker of the
luminal lineage, and co-expression of these factors in a
single cell is indicative of the MaSC state (Guo et al.,
2012). In shLuc-GFP infected control cells, we found no
change in the expression of SNAI2 and SOX9, relative
to uninfected control cells. However, cells infected with
shBCL11B-GFP showed a marked decrease in SOX9
expression relative to tissue-matched uninfected cells
(Figure 7C). This result further suggests that loss of
BCL11B leads to a release from the dual-positive stem
cell state and a bias toward basal differentiation, due to
de-repression of basal lineage commitment of MaSCs
(Figure 7D).DISCUSSION
Here, we present an experimental strategy to identify TFs
that control stem cell self-renewal and lineage commit-
ment decisions. This approach directly addresses funda-
mentally important questions about how the stem cell’s
behavior is controlled, without the need for physically
isolating distinct cell states based on marker expression.
Applying this strategy to the humanmammary gland iden-
tified a number of known regulators ofmammary cell states
(SOX9, SNAI2, and GATA3), as well as numerous additional
candidates.
Our strategy relies on the simple assumption that factors
capable of driving the specification of a cell state must be
stably and actively repressed in all alternative states. While
not the only way to stably repress a gene’s expression,
epigenetic modification (such as the trimethylation of his-
tone H3K27) is one mechanism by which stable gene inac-
tivation can occur. Thus, while our strategy cannot claim to
identify all such factors, we were confident that the factors
it did highlight would be enriched for functionally crucial
genes.
Using a combination of canonical and recently devel-
oped 2D and 3D culture assays to assess humanMaSCprop-
erties in vitro, we have demonstrated that one of these
candidates, BCL11B, is required for self-renewal. BCL11B’s
expression is enriched in stem and progenitor cell types,tissues grown in hydrogels for 14 days (n = 2,187 shLuc-GFP-negative
cells, and 121 shBCL11B GFP-positive cells; three independent exper
(D) Model of BCL11B’s role in MaSC self-renewal and basal differentia
Scale bars, 50 mm.relative to mature cell types, and drives MaSC self-renewal
by preventing basal lineage commitment. This role is remi-
niscent of the role of SNAI2, an EMT TF that inhibits
luminal differentiation and is required for bipotency of
MaSCs. This raises the possibility that BCL11B may act as
a reciprocal differentiation inhibitor, preventing basal line-
age commitment, while SNAI2 prevents luminal lineage
commitment.
Interestingly, a recent study also revealed a crucial role for
Bcl11b in maintenance of the MaSC state in the murine
mammary gland (Cai et al., 2017). This study, however,
suggested that Bcl11b expression drives quiescence in
MaSCs. We find that, in human MaSCs, BCL11B-express-
ing cells show no indication of quiescence, as they
contribute to 2D colony formation (Figures 6B–6D) and
3D tissue development (Figures 7B and 7C). In addition,
BCL11B-expressing cells in fixed patient tissue sections
comprise both cycling andnon-cycling cells, as determined
by Ki-67 staining (Figures 6E and 6F). In human MaSCs,
our results suggest that BCL11B drives self-renewal by in-
hibiting commitment to the basal lineage and subsequent
differentiation, rather than by inhibiting proliferation to
drive quiescence.
While more work is needed to clarify the reason for these
distinctions, it is possible that the BCL11B+ MaSCs in the
human and mouse glands perform distinct functions.
One key developmental difference between the human
and murine gland is that the murine gland only produces
functional terminal ductal lobular units (TDLUs) upon
pregnancy, whereas the human gland undergoes more
extensive development during puberty. Cai et al. (2017)
limited their study to virgin mice, but the possibility re-
mains that Bcl11b+ MaSCs could become proliferative
once TDLUs form. This hypothesis suggests that the prolif-
eration of BCL11B+MaSCsmay contribute tomaintenance
of the gland at this more advanced stage, although further
studies are required to directly test this possibility.
Previous studies of Bcl11b in murine T cells suggest that
its expression is regulated by numerous TFs known to
also have key roles in MEC biology (Li et al., 2013; Longa-
baugh et al., 2017). In those cells, Bcl11b’s expression is
controlled by a far downstream enhancer, which contains
binding sites for Gata3 (a regulator of luminal fate commit-
ment; Asselin-Labat et al., 2007), Runx1 (a regulator of
stem cell differentiation; Sokol et al., 2015), and Tcf7
(a TF activated downstream ofWnt signaling, which drives
MaSC self-renewal; Zeng and Nusse, 2010). Of note, TCF7
was also a TF that appeared in our list of J-bivalent TFs,cells, 231 shLuc-GFP-positive cells, 3,678 shBCL11B GFP-negative
iments).
tion.
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indicating that its expression may have an important role
in regulating theMaSC state. While it is unknownwhether
these three factors activate or repress BCL11B transcription
in the humanmammary gland, this downstream enhancer
could act as a central hub for MEC lineage commitment
signaling.EXPERIMENTAL PROCEDURES
Ethics Statement
Patient reduction mammoplasty tissue samples that would other-
wise have been discarded as medical waste following surgery
were obtained in compliance with all relevant laws, using proto-
cols approved by the institutional review board at Maine Medical
Center. Since tissues were fully anonymized before transfer, this
research was provided exemption status by the Committee on
the Use of Humans as Experimental Subjects at the Massachusetts
Institute of Technology. All patients enrolled in this study signed
an informed consent form to agree to participate in this study
and for publication of the results.Cells and Tissues
MCF10A cells were obtained from ATCC and cultured in mam-
mary epithelium growth medium (MEGM) (Lonza CC-3150)
supplemented with 100 ng/mL cholera toxin (Sigma-Aldrich),
13 GlutaMax, and 13 penicillin and streptomycin (Gibco).
Reduction mammoplasty samples were obtained from the
BioBank at Maine Medical Center. Upon arrival, tissue was chop-
ped into roughly 3 mm3 fragments using a scalpel, and then incu-
bated with 3 mg/mL collagenase (Roche) and 0.7 mg/mL hyal-
uronidase (Sigma-Aldrich) in MEGM at 37C overnight.
Epithelial tissue was separated from stroma by centrifugation;
washed; and frozen in 90% fetal bovine serum (FBS), 10%
DMSO for long-term storage. Following thawing, samples were
depleted for fibroblasts via incubation at 37C in DMEM with
10% FBS for 1 hr.Chromatin Immunoprecipitation Sequencing
Chromatin immunoprecipitation was performed as previously
described (Lee et al., 2006). 1 3 108 MCF10A cells were fixed in
11% formaldehyde solution for 10 min at room temperature
(RT), quenched with 100 mM glycine, and collected by scraping.
Cells were lysed in LB1 (lysis buffer 1) for 10 min at 4C, and resus-
pended in LB2 for 10 min at RT. Cells were then resuspended
in LB3 for sonication. Samples were sonicated for 5 min total
(30 s3 10 with 1min gaps; 18–21W; QSonicamicrotip sonicator).
Following sonication, samples were spun at 20,000 g and split into
three tubes (for H3K4me3, H3K27me3, H3K79me2). At this time,
50 mL was saved as an input control.
Magnetic beads (Dynabeads; Invitrogen) were prepared by
washing in block (0.5%BSA in PBS) followed by an overnight incu-
bation at 4C in the appropriate antibody ([H3K4me3; Millipore
#07-473; lot JBC 1888194; 1:50], [H3K27me3; Abcam Ab6002;
lot GR 19843-1; 1:20], or [H3K79me2; Abcam Ab3594-100; lot
803369; 1:50]). In addition, 25 mL of antibody-bound beads was1142 Stem Cell Reports j Vol. 10 j 1131–1145 j March 13, 2018added to the sonicated sample and incubated overnight at 4C
on a rotator.
The samples were washed with buffers B, C, and I, and eluted
in 200 mL of elution buffer at 65C for 15 min. Crosslinks were
reversed overnight at 65C. Samples were then digested for
2 hr with 400 mg/mL RNase A at 37C followed by 400 mg/mL
Proteinase K digestion at 55C for 2 hr. DNA was then extracted
with phenol:chloroform:isoamyl and pelleted with ice-cold
ethanol. Samples were resuspended in water and analyzed on a
1% agarose gel.
Samples were sequenced at the Whitehead Genome Technol-
ogy Core using the Illumina HiSeq 2000 platform and TruSeq
adapters. Reads were aligned to the hg38 reference genome
using Bowtie2 (version 2.3.1) (Langmead and Salzberg, 2012) us-
ing default parameters except that up to one mismatch was
accepted in the seed sequence. Peaks were identified by
MACS2 (version 2.1.1) (Zhang et al., 2008) using the input
sample as a control while bypassing the shifting model and
with the broad peak setting with a broad cutoff of 0.05 for
H3K4me3 and H3K79me2 conditions. To determine bivalence,
peaks were first associated with their closest gene, where anti-
sense genes were collapsed onto their respective genes, using
the HOMER software suite (version 4.9.1) (Heinz et al., 2010).
Next, peaks were filtered to keep only peaks within 20 kb
upstream or 5 kb downstream of a transcriptional start site.
Genes that retained a H3K4me3 peak and a H3K27me3 peak
were identified as bivalent. These genes were then visually
inspected to eliminate false-positives, yielding a final set of
55 bivalent genes.Immunofluorescence
Immunofluorescence was performed as previously described for
2D (Sokol et al., 2015) and 3D (Miller et al., 2017; Sokol et al.,
2016) culture. Antibodies and stains used were BCL11B (Cell
Signaling, 12120; 1:200), KRT14 (Life Technologies, RB-9020-P;
1:300), KRT8/18 (Vector, VP-C407; 1:500), SNAI2 (Cell Signaling,
9585; 1:400), SOX9 (Sigma, WH0006662M2; 1:50), Ki-67 (Cell
Signaling, 9449; 1:800), DAPI (Life Technologies, D1306), Phal-
loidin-AF647 (Life Technologies, A22287; 1:100), anti-rabbit
IgG- AF488 (Cell Signaling, 4,412, 1:1,000), and anti-mouse
IgG-AF555 (Cell Signaling, 4409, 1:1,000).
Immunofluorescence on human tissue was performed as previ-
ously described (Skibinski et al., 2014). Primary and secondary an-
tibodies used were BCL11B (Cell signaling, 12120; 1: 100), Ki-67
(Cell Signaling, 9585; 1: 400), anti-Rabbit IgG-AF555 (Life Technol-
ogies, A21430; 1:500), and anti-Mouse IgG-AF488 (Life Technolo-
gies, A11001; 1:500). Sections were treated with ProLong Gold
antifade reagent with DAPI (Life Technologies, P36935) and
mounted with coverslips.Microscopy
Epifluorescence microscopy for imaging of 2D colony assays
was done using a Nikon TE-2000 microscope. Microscopy of
immunofluorescence stained hydrogel cultures and BCL11B
in MCF10A cells was done using a Zeiss LSM-700 confocal
microscope. Brightfield microscopy was done using a Zeiss
Axiovert 25.
RT-PCR
RNA was collected from MCF10A cells in 2D culture using RNeasy
kit (Qiagen) and treated with RNase-free DNase (Qiagen). RNAwas
reverse transcribed into cDNA using iScript (Bio-Rad). PCR was run
using ExTaq (Takara) and primers listed in Table S2 for 40 cycles.
PCR product was run on a 4% agarose gel and detected with
ethidium bromide (Sigma).
Single-Cell Real-Time qRT-PCR
One cell per well was sorted using a flow cytometer into 96-well
plates and lysed using CellsDirect Kit (Thermo Fisher). Genomic
DNA was degraded using DNase I (Thermo Fisher). Reverse tran-
scription was performed using SuperScript III (Thermo Fisher)
and pooled pre-amplification primers at 50 nM each (see
Table S3). Twenty cycles of pre-amplification PCR were performed
using CellsDirect Kit (Thermo Fisher) and pooled primers listed in
Table S3. Free primers were degraded using Exonuclease I (New
England BioLabs).
Pre-amped single-cell cDNA was then used to perform real-time
qRT-PCR using SsoFast EvaGreen Gene Expression (Fluidigm) pro-
tocols with 96.96 Dynamic Array plates on a BioMark HD System
(Fluidigm). Primers used are listed in Table S2.
Computational Analyses and Statistics
Clustering and principal component analysis were performed us-
ing MATLAB. All statistics were calculated using GraphPad Prism.
Colony Assay
Primary mammary tissue from elective reduction mammoplasties
was dissociated to single cells and plated at clonogenic density in
tissue culture plates with the addition of either shLuc (shCntrl)
or shBCL11B lentivirus. Colonies were grown for 10 days and
then fixed and stained using immunofluorescence for expression
of KRT14 and KRT8/18. Colonies were classified as luminal, basal,
mixed, or stem using CellProfiler. Briefly, cells were first identified
using DAPI. Corresponding KRT14 and KRT8/18 signal was then
scored for each cell. Colonies in which all cells expressed KRT14
only were classified as basal. Colonies in which all cells expressed
KRT8/18 only were classified as luminal. Colonies with a mixture
of KRT14-only and KRT8/18-only cells were classified as mixed.
Colonies with cells that co-expressed KRT14 and KRT8/18 were
classified as stem.
3D Culture
3D culture of primary tissue fragments using hydrogels was per-
formed as previously described (Miller et al., 2017; Sokol et al.,
2016). Culture ofMCF10A cell lines in collagen gels was performed
as previously described (Sokol et al., 2015).
Lentiviral Production and Infection
Lentivirus production and cell line infection were performed as
previously described (Gupta et al., 2005). To infect tissue frag-
ments, tissues were cultured overnight in MEGM supplemented
with 10 mg/mLprotamine sulfate and concentrated lentivirus in ul-
tra-low attachment tissue culture plates. After overnight incuba-
tion, tissue fragments were seeded into hydrogel cultures.ACCESSION NUMBERS
The accession number for ChIP-seq data reported in this paper is
GEO: GSE109721.
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